Sex Differences in Outcomes of Chimeric Antigen Receptor (CAR) T‐Cell Therapy
ABSTRACT Background Chimeric Antigen Receptor (CAR) T‐cell therapy has arisen as a revolutionary treatment for hematologic malignancies. Our study aimed to evaluate how sex differences affect outcomes and complications following CAR T‐cell therapy. Methods Utilizing the Nationwide Readmissions Datab...
Saved in:
| Main Authors: | Jia Yi Tan, Yong Hao Yeo, Hermon Wong Kha Kin, Qi Xuan Ang, Mohammad Muhsin Chisti, Daniel Ezekwudo, Talal Hilal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70831 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Predictive Value of Red Blood Cell Distribution Width in Hodgkin Lymphoma in Iraqi Patients
by: Alaa Kadhum, et al.
Published: (2025-06-01) -
The Association between Allergies and Hematologic Tumors — A Review
by: Aleksandra Hrapkowicz, et al.
Published: (2024-11-01) -
Global, regional, and national economic burden of hematologic malignancies (1990–2021) with projections to 2050
by: Zhexian Li, et al.
Published: (2025-06-01) -
Advances in Chimeric Antigen Receptor T-cell therapy for hematologic malignancies and autoimmune conditions: a review of the 2024 American Society of Hematology Annual Meeting
by: Samuel Davis, et al.
Published: (2025-06-01) -
Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022Research in context
by: Kexin Sun, et al.
Published: (2025-05-01)